RAPGEF4 and type 2 diabetes mellitus: As illustrated by the recent finding of altered fusion pore behavior in type-2 diabetes (Collins et al., 2016), Epac-dependent fusion pore regulation may have profound consequences for islet physiology and glucose metabolism in vivo.